Fachliteratur Gastroenterologie: Neoplasien der Leber

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Leber » Neoplasie

21. November 2024

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Schrift:

Seite 1 von 3502


	Artikel 1 - 20 / 70031

	Risk factors and nomogram predictive models for postsurgical progression/hyperprogression recurrence in hepatocellular carcinoma with macroscopic vascular invasion. World J Surg Oncol Huang Y, Su Y, Chen Y, Xu J, Zhu L, Wei H, Qin S, Peng Y, Qi L. PMID: 39563379 [PubMed - indexed for MEDLINE]
	Prediction of the early hepatocellular carcinoma development in patients with chronic hepatitis B virus infection using gadoxetic acid-enhanced magnetic resonance imaging. BMC Cancer Tang M, Xu D, Jin H, Song C, Zhou X, Cai H, Li L, Chen M, Wu Y, Luo Y, Chen Y, Feng ST. PMID: 39563280 [PubMed - indexed for MEDLINE]
	Biomarkers of systemic treatment response: MR images of intratumoral fat deposition in colorectal liver metastases (CRLM) after chemotherapy. Int J Colorectal Dis Morawska I, Pasicz K, Cieszanowski A. PMID: 39562379 [PubMed - indexed for MEDLINE]
	Interventional Oncology Meets Immuno-oncology: Combination Therapies for Hepatocellular Carcinoma. Radiology Bitar R, Salem R, Finn R, Greten TF, Goldberg SN, Chapiro J. PMID: 39560477 [PubMed - indexed for MEDLINE]
	Dynamics trajectory of patient-reported quality of life and its associated risk factors among hepatocellular carcinoma patients receiving immune checkpoint inhibitors: a prospective cohort study. Front Immunol You XM, Lu FC, Li FR, Zhao FJ, Huo RR. PMID: 39559352 [PubMed - indexed for MEDLINE]
	Comparative analysis of efficacy and safety between D-TACEâ€‰+â€‰HAICâ€‰+â€‰lenvatinib and D-TACEâ€‰+â€‰lenvatinib in the treatment of unresectable massive hepatocellular carcinoma. BMC Cancer Lu H, Liang B, Zheng C, Xia X. PMID: 39558198 [PubMed - indexed for MEDLINE]
	Trends in Hepatocellular Carcinoma Mortality Rates in the US and Projections Through 2040. JAMA Netw Open Qiu S, Cai J, Yang Z, He X, Xing Z, Zu J, Xie E, Henry L, Chong CR, John EM, Cheung R, Ji F, Nguyen MH. PMID: 39556395 [PubMed - indexed for MEDLINE]
	The CRAFITY score emerges as a paramount prognostic indicator in hepatocellular carcinoma patients received Lenvatinib and Pembrolizumab. Front Immunol Wu W, Yang Z, Zou H, Long T, Zhou Z, Zhang Y, Chen M, Hu D. PMID: 39555053 [PubMed - indexed for MEDLINE]
	Risk of Hepatocellular Carcinoma with Glucagon-like Peptide-1 receptor agonist treatment in patients: a systematic review and meta-analysis. BMC Endocr Disord Shabil M, Khatib MN, Ballal S, Bansal P, Tomar BS, Ashraf A, Kumar MR, Sinha A, Rawat P, Gaidhane AM, Sah S, Daniel AS, Yappalparvi A, Bushi G. PMID: 39551761 [PubMed - indexed for MEDLINE]
	Safety of local thermal ablation in hepatocellular carcinoma patients with cirrhosis and severe thrombocytopenia. Sci Rep Zhao F, Zhang T, Yang Q, Zhang X, Yang F, Qian N. PMID: 39550438 [PubMed - indexed for MEDLINE]
	Investigating the diagnostic and prognostic significance of genes related to fatty acid metabolism in hepatocellular carcinoma. BMC Gastroenterol Zhao SS, Bai RR, Zhang BH, Sun XR, Huang N, Chen Y, Sun ZJ, Sun LM, Zhang Y, Cui ZQ. PMID: 39548390 [PubMed - indexed for MEDLINE]
	Role and therapeutic potential of E3s in the tumor microenvironment of hepatocellular carcinoma. Front Immunol Wang H, Li Q, Tang Q, Shi G, Wu G, Mao X, Wu C, Zhang L, Liu J, Li J, Li B. PMID: 39544935 [PubMed - indexed for MEDLINE]
	Hepatobiliary-Phase Hypointense Nodules Without Arterial-Phase Hyperenhancement: Developing a Risk Stratification for Hypervascular Transformation Based on a Real-World Observational Cohort Study. Technol Cancer Res Treat Li N, Wang Y, Yang L, Yang C, Zeng M. PMID: 39544080 [PubMed - indexed for MEDLINE]
	Immune dynamics shaping pre-metastatic and metastatic niches in liver metastases: from molecular mechanisms to therapeutic strategies. Mol Cancer Zhu C, Liao JY, Liu YY, Chen ZY, Chang RZ, Chen XP, Zhang BX, Liang JN. PMID: 39543660 [PubMed - indexed for MEDLINE]
	Nomogram for predicting early recurrence of hepatocellular carcinoma with narrow resection margin. Sci Rep Zhang J, Wang Z, Wu Q, Zeng J, Liu J, Zeng J. PMID: 39543345 [PubMed - indexed for MEDLINE]
	Hepatic arterial infusion chemotherapy combined with systemic therapy sequentially or simultaneously for advanced hepatocellular carcinoma. Cancer Immunol Immunother Cao YZ, Pan JY, Zheng GL, An C, Zuo MX. PMID: 39540963 [PubMed - indexed for MEDLINE]
	A Novel Prognostic Nomogram Based on TIGIT and NKG2A Can Predict Relapse-Free Survival of Hepatocellular Carcinoma After Hepatectomy. Cancer Med Wang J, Cao Y, Tian Y, Dai C, Jin T, Xu F. PMID: 39540362 [PubMed - indexed for MEDLINE]
	The Extent of Tumor in the Peritoneum and Liver Influences Outcomes After Surgery for Synchronous Liver and Peritoneal Colorectal Metastases: A Cohort Study. J Gastrointest Cancer Salas PS, Urdzik J, Graf W, Isaksson B, Birgisson H. PMID: 39537942 [PubMed - indexed for MEDLINE]
	Extracellular vesicles in hepatocellular carcinoma: unraveling immunological mechanisms for enhanced diagnosis and overcoming drug resistance. Front Immunol Su L, Yue Y, Yan Y, Sun J, Meng L, Lu J, Zhang L, Liu J, Chi H, Liu S, Yang Z, Tang X. PMID: 39530097 [PubMed - indexed for MEDLINE]
	Risk factors for wound complications after associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) compared to repeated liver resection - a propensity score matching analysis. Langenbecks Arch Surg Khajeh E, Sabetkish N, Ramouz A, Werba A, Klotz R, Michalski CW, Mehrabi A, Pianka F. PMID: 39535576 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 70031

Seite 1 von 3502



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung